PoliticsMostly Factual · factual reporting (3 of 5)Outlet ratings by Media Bias/Fact Check 
Trump administration fast-tracks ibogaine research for PTSD
Gabrielle M. Etzel·Washington Examiner·November 12, 2026

The Trump administration announced on Thursday a multi-department investment in fast-tracking research for the psychotropic drug ibogaine to treat post-traumatic stress disorder and other serious mental illnesses. Health and Human Services Secretary Robert F. Kennedy Jr. announced a more than $25 million investment from his department, along with the Department of Veterans Affairs, to speed […]
Read the full story at Washington Examiner →